Table 1.
Association Between miR-30a Expression and Clinicopathological Features.
| Clinicopathological Features | N | miR-30a Expression | P Value |
|---|---|---|---|
| Age, years | .614 | ||
| ≤60 | 21 | 0.51 (0.23) | |
| >60 | 43 | 0.49 (0.20) | |
| Gender | .631 | ||
| Female | 29 | 0.51 (0.28) | |
| Male | 35 | 0.49 (0.21) | |
| Tumor size (cm) | .183 | ||
| ≤2 | 24 | 0.54 (0.21) | |
| >2 | 40 | 0.47 (0.20) | |
| Tumor differentiation | .019a | ||
| Well/moderate | 26 | 0.57 (0.24) | |
| Poor | 38 | 0.44 (0.16) | |
| TNM stage | .442 | ||
| I + II | 40 | 0.51 (0.17) | |
| III + IV | 24 | 0.47 (0.26) | |
| Lymph node metastasis | .015a | ||
| Positive | 37 | 0.44 (0.19) | |
| Negative | 27 | 0.56 (0.21) | |
| Distant metastasis | .123 | ||
| Positive | 15 | 0.57 (0.24) | |
| Negative | 49 | 0.47 (0.19) |
Abbreviations: miR-30a, MicroRNA-30a; TNM, tumor node metastasis.
aStatistically significant (P < .05).